4//SEC Filing
SBI CROSS-BORDER ADVANTAGE FUND 4
Accession 0000898432-24-000962
CIK 0001834645other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 8:30 AM ET
Size
13.5 KB
Accession
0000898432-24-000962
Insider Transaction Report
Form 4
Peak Bio, Inc.PKBO
IKBC-SBI BIO FUND 1
10% Owner
Transactions
- Other
Common Stock
2024-10-07−83,800→ 0 total - Disposition to Issuer
Common Stock
2024-11-14−3,621,489→ 0 total
SBI HEALTHCARE FUND I
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2024-11-14−3,621,489→ 0 total - Other
Common Stock
2024-10-07−83,800→ 0 total
SBI CROSS-BORDER ADVANTAGE FUND
10% Owner
Transactions
- Other
Common Stock
2024-10-07−83,800→ 0 total - Disposition to Issuer
Common Stock
2024-11-14−3,621,489→ 0 total
SBI INVESTMENT KOREA CO., LTD.
10% Owner
Transactions
- Other
Common Stock
2024-10-07−83,800→ 0 total - Disposition to Issuer
Common Stock
2024-11-14−3,621,489→ 0 total
Footnotes (4)
- [F1]On October 7, 2024 (October 8, 2024 Korea time), in connection with the dissolution of SBI KIS 2016-1 FUND ("2016-1 Fund"), 2016-1 Fund distributed in-kind, for nominal consideration, all of the securities of the Issuer owned by 2016-1 Fund to SBI Investment KOREA Co., Ltd. ("SBI"), the general partner of 2016-1 Fund.
- [F2]This Form 4 reports securities transacted pursuant to the terms of the Agreement and Plan of Merger, dated as of March 4, 2024, as amended (the "Merger Agreement"), by and among the Issuer, Akari Therapeutics Plc ("Parent"), and Pegasus Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of November 14, 2024, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger").
- [F3]Consists of 571,606 shares of common stock held by SBI, 251,418 shares of common stock held by SBI Cross-border Advantage Fund, an affiliate of SBI, 599,202 shares of common stock held by SBI Healthcare Fund 1, an affiliate of SBI, 1,601,067 shares of common stock held by IBKC-SBI Bio Fund 1, an affiliate of SBI, 419,017 shares of common stock held by Global Gateway Fund 1, an affiliate of SBI, and 179,179 shares of common stock held by 2019 SBI Job Creation Fund, an affiliate of SBI.
- [F4]At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock was cancelled and converted into the right to receive 0.2935 (the "Exchange Ratio") American Depositary Shares ("ADSs") of Parent, each ADS representing a number of ordinary shares, par value $0.0001 per share (the "Ordinary Shares") of Parent.
Documents
Issuer
Peak Bio, Inc.
CIK 0001834645
Entity typeother
IncorporatedKorea, Republic of
Related Parties
1- filerCIK 0001966535
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 8:30 AM ET
- Size
- 13.5 KB